Cargando…
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
BACKGROUND: Quercetin, a well-known naturally occurring polyphenol, has recently been shown by molecular docking, in vitro and in vivo studies to be a possible anti-COVID-19 candidate. Quercetin has strong antioxidant, anti-inflammatory, immunomodulatory, and antiviral properties, and it is characte...
Autores principales: | Di Pierro, Francesco, Derosa, Giuseppe, Maffioli, Pamela, Bertuccioli, Alexander, Togni, Stefano, Riva, Antonella, Allegrini, Pietro, Khan, Amjad, Khan, Saeed, Khan, Bilal Ahmad, Altaf, Naireen, Zahid, Maria, Ujjan, Ikram Din, Nigar, Roohi, Khushk, Mehwish Imam, Phulpoto, Maryam, Lail, Amanullah, Devrajani, Bikha Ram, Ahmed, Sagheer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197660/ https://www.ncbi.nlm.nih.gov/pubmed/34135619 http://dx.doi.org/10.2147/IJGM.S318720 |
Ejemplares similares
-
The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial
por: Ujjan, Ikram Din, et al.
Publicado: (2023) -
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
por: Di Pierro, Francesco, et al.
Publicado: (2021) -
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
por: Di Pierro, Francesco, et al.
Publicado: (2023) -
The clinical and demographical profile of Coronavirus illness: The tale of Tablighi Jamaat and Zaireen in Quarantine / Isolation center at Sukkur and Hyderabad
por: Ujjan, Ikram Din, et al.
Publicado: (2020) -
Impact of ACE2 gene variations on COVID-19 pathogenicity in Pakistani patients
por: Waryah, Yar Muhammad, et al.
Publicado: (2023)